Tri Locum Partners LP Novo Nordisk A S Transaction History
Tri Locum Partners LP
- $374 Million
- Q3 2024
A detailed history of Tri Locum Partners LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Tri Locum Partners LP holds 67,257 shares of NVO stock, worth $6.84 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
67,257
Previous 63,811
5.4%
Holding current value
$6.84 Million
Previous $9.11 Million
12.08%
% of portfolio
2.14%
Previous 2.35%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,953Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.05 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.46 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.46 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.35 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.24 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $230B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...